PIK3C3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.536300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.912400E-01
Normal-vs-Stage2
8.270200E-02
Normal-vs-Stage3
1.333880E-02
Normal-vs-Stage4
2.946600E-01
Stage1-vs-Stage2
7.823000E-01
Stage1-vs-Stage3
1.698780E-01
Stage1-vs-Stage4
9.511400E-01
Stage2-vs-Stage3
1.011180E-01
Stage2-vs-Stage4
8.937400E-01
Stage3-vs-Stage4
1.909830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.412100E-02
Normal-vs-AfricanAmerican
3.376200E-01
Normal-vs-Asian
2.354400E-02
Caucasian-vs-AfricanAmerican
3.181200E-01
Caucasian-vs-Asian
1.228630E-01
AfricanAmerican-vs-Asian
5.618200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.238300E-02
Normal-vs-Female
1.487600E-01
Male-vs-Female
5.813700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.667700E-02
Normal-vs-Age(41-60Yrs)
2.198400E-01
Normal-vs-Age(61-80Yrs)
4.146300E-02
Normal-vs-Age(81-100Yrs)
2.381400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.616800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.856400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.808200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.802300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.586800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.959200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.031600E-02
Normal-vs-Daily Drinker
2.222600E-03
Normal-vs-Weekly Drinker
8.828200E-02
Normal-vs-Occasional Drinker
8.505600E-02
Normal-vs-Social Drinker
3.934600E-01
Non Drinker-vs-Daily Drinker
3.742000E-01
Non Drinker-vs-Weekly Drinker
4.785400E-01
Non Drinker-vs-Occasional Drinker
1.074400E-01
Non Drinker-vs-Social Drinker
5.289600E-02
Daily Drinker-vs-Weekly Drinker
1.403370E-01
Daily Drinker-vs-Occasional Drinker
1.126200E-02
Daily Drinker-vs-Social Drinker
2.679500E-02
Weekly Drinker-vs-Occasional Drinker
5.084000E-01
Weekly Drinker-vs-Social Drinker
3.047600E-01
Occasional Drinker-vs-Social Drinker
5.244400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.265400E-01
Normal-vs-Grade 2
8.180600E-01
Normal-vs-Grade 3
7.749800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.063200E-01
Grade 1-vs-Grade 3
8.420400E-01
Grade 1-vs-Grade 4
5.265400E-01
Grade 2-vs-Grade 3
4.521800E-01
Grade 2-vs-Grade 4
8.180600E-01
Grade 3-vs-Grade 4
7.749800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.832400E-02
Normal-vs-NonDiabetic
3.140400E-02
Diabetic-vs-NonDiabetic
7.788600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.777970E-03
Normal-vs-NoPancreatitis
4.306500E-02
Pancreatitis-vs-NoPancreatitis
3.547900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.171360E-01
Normal-vs-N1
8.798400E-02
N0-vs-N1
7.836000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.894100E-02
Normal-vs-TP53-NonMutant
2.508200E-01
TP53-Mutant-vs-TP53-NonMutant
3.059500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
